FDA Approves Expanded Indication for Lumryz in Pediatric Patients with Narcolepsy

Expanded approval of Lumryz offers a once-nightly treatment option for younger patients, eliminating the need for traditional narcolepsy treatments that often require multiple doses throughout the night.